Preclinical animal study of the NIPRO-ventricular assist device for use in pediatric patients

  • Noritsugu Naito
  • Yoshiaki Takewa
  • Satoru Kishimoto
  • Kei Iizuka
  • Toshihide Mizuno
  • Tomonori Tsukiya
  • Minoru Ono
  • Eisuke Tatsumi
Original Article Artificial Heart (Clinical)


Although the outcomes of patients with end-stage heart failure treated with implantable left ventricular assist devices have improved, extracorporeal left ventricular assist devices continue to play an important role, especially in pediatric patients. The present study aimed to examine the long-term biocompatibility of a small-sized extracorporeal pneumatic left ventricular assist device (NIPRO-LVAD) used in a 30- to 90-day animal experiment. The NIPRO-LVAD was designed for pediatric patients or small-sized adults. The left ventricular assist device system was installed in four adult Shiba goats weighing 25.7 ± 4.78 kg via a left thoracotomy. The outflow graft was sewn to the descending aorta and the inflow cannula was placed in the left ventricle through the left ventricular apex. Oral antiplatelet (aspirin) and oral anticoagulation therapies (warfarin) were also administered. Three out of four animals survived for a 30-day period and two goats survived for 90 days. One animal was killed early because of low pump flow due to obstruction of the inflow cannula by a left ventricular endocardial vegetation. The blood pump exhibited sufficient hydrodynamic performance with blood flows of 1.5–2.0 L/min. The animals’ laboratory values were within normal limits by postoperative day 7. There was no significant thrombus formation on the housing, diaphragm, or valves of the explanted pumps. Based on the biocompatibility demonstrated in this animal study, the explanted small-sized pump may be suitable for use in left ventricular assist device systems for pediatric patients.


Left ventricular assist device Pediatric cardiothoracic surgery Thrombosis 



This study was conducted under a cooperative research and development agreement between the National Cerebral and Cardiovascular Center and NIPRO corporation.

Compliance with ethical standards

Conflict of interest

Eisuke Tatsumi has received research funding from NIPRO corporation. The other authors declare that they have no conflicts of interest.


  1. 1.
    Nishimura T. Current status of extracorporeal ventricular assist devices in Japan. J Artif Organs. 2014;17:211–9.CrossRefPubMedGoogle Scholar
  2. 2.
    The Japanese Society for Heart Transplantation. Registry 2015. Accessed 1 Oct 2017.
  3. 3.
    Nakatani T, Fukushima N, Ono M, Saiki Y, Matsuda H, Nunoda S, Sawa Y, Isobe M. The registry report of heart transplantation in Japan (1999–2014). Circ J. 2016;80:44–50.CrossRefPubMedGoogle Scholar
  4. 4.
    The Japanese Association for Clinical Ventricular Assist Systems.Registry 2016. Accessed 1 Oct 2017.
  5. 5.
    Sandica E, Blanz U, Mime LB, Shultz-Kaizler U, Kececioglu D, Haas N, Kirchner G, Knyphausen E, Lauenroth V, Morshuis M. Long-term mechanical circulatory support in pediatric patients. Artif organs. 2016;40:225–32.CrossRefPubMedGoogle Scholar
  6. 6.
    Booth KL, Roth SJ, Thiagarajan RR, Almodovar MC, dal Nido PJ, Laussen PC. Extracorporeal membrane oxygenation support of the Fontan and bidirectional Glenn circulations. Ann Thorac Surg. 2000;70:1341–8.Google Scholar
  7. 7.
    Conway J, Louis JS, Morales DLS, Law S, Tjossern C, Humpl T. Delineating survival outcomes in children < 10 kg bridged to transplant or recovery with the Berlin Heart EXCOR ventricular assist device. JACC Heart Fail. 2015;1:71–7.Google Scholar
  8. 8.
    Fan Y, Weng YG, Huebler M, Morales D, Franz N, Xiao YB, Potapov E, Hetzer R. Predictors of in-hospital mortality in children after long-term ventricular assist device insertion. J Am Coll Cardiol. 2011;58:1183–90.CrossRefPubMedGoogle Scholar
  9. 9.
    Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, Young JB. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg. 2012;144:588–603.CrossRefGoogle Scholar
  10. 10.
    Mascio CE. The use of ventricular assist device support in children: the state of the art. Artif Organs. 2015;35:14–20.CrossRefGoogle Scholar
  11. 11.
    Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA. Pediatric Heart Transplant Study Investigators. Outcomes of children bridged to transplantation with ventricular assist devices: a multi-institutional study. Criculation. 2006;113:2313–9.CrossRefGoogle Scholar
  12. 12.
    Takano H, Nakatani T, Taenaka Y, Kitoh Y, Hiramori K, Haze K, Itoh A, Fujita T, Manabe H. Treatment of acute profound heart failure by ventricular assist device. Jpn Circ J. 1992;56:100–10.CrossRefPubMedGoogle Scholar
  13. 13.
    Saito S, Matsumiya G, Sakaguchi T, Fujita T, Kuratani T, Ichikawa H, Sawa Y. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs. 2009;12:27–34.CrossRefPubMedGoogle Scholar
  14. 14.
    Cassidy J, Dominguez T, Haynes S, Burch M, Kirk R, Hoskote A, Smith J, Fenton M, Griselli M, Hsia TY, Ferguson L, Doorn CV, Hasan A, Karimova A. A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device—the United Kingdom experience. J Heart Lung Trasnplant. 2013;32:1101–6.CrossRefGoogle Scholar
  15. 15.
    Hoganson DM, Boston US, Gazit AZ, Canter CE, Eghtesady P. Successful bridge through transplantation with Berlin Heart ventricular assist device in a child with wailing Fontan. Ann Thorac Surg. 2015;99:707–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Morales DLS, Almond CSD, Jaquiss RDB, Rosenthal DN, Naftel DC, Massicotte MP, Humpl T, Kroslowitz R, Devaney EJ, Canter CE, Fynn-Thompson F, Reinhartz O, Imamura M, Ghanayem NS, Buchholz H, Furness S, Mazor R, Gandhi SK, Fraser CD. Bridge children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Hart EXCOR ventricular assist device. J Heart Lung Transplant. 2011;30:1–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Botha P, Solana R, Cassidy J, Parry G, Kirk R, Hasan A, Griselli M. The impact of mechanical circulatory support on outcomes in paediatric heart transplantation. Eur J Cardiothorac Surg. 2013;44:836–40.CrossRefPubMedGoogle Scholar
  18. 18.
    Tanaka H, Tsukiya T, Tatsumi E, Mizuno T, Hidaka T, Okubo T, Osada T, Miyamoto S, Taenaka Y. Initial in vivo evaluation of the newly developed axial flow turbo pump with hydrodynamic bearings. J Artif Organs. 2011;14:31–8.CrossRefPubMedGoogle Scholar
  19. 19.
    McGee E Jr, Chorpenning K, Brown MC, Brenznock E, Larose JA, Tamez D. In vivo evaluation of the HeartWare MVAD Pump. J Heart Lung Transplant. 2014;33:366–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Tuzun E, Roberts K, Cohn WE, Sargin M, Gemmato CJ, Radovancevic B, Frazier OH. In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart I J. 2007;34:406–11.Google Scholar
  21. 21.
    Biran R, Pond D. Heparin coatings for improving blood compatibility of medical devices. Adv Drug Deliv Rev. 2017;112:12–23.CrossRefPubMedGoogle Scholar
  22. 22.
    Nishinaka T, Tatsumi E, Katagiri N, Ohnishi H, Mizuno T, Shioya K, Tsukiya T, Homma A, Kashiwabara S, Tanaka H, Sato M, Taenaka Y. Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a seal-less centrifugal pump and a diffusion membrane oxygenator. J Artif Organs. 2007;10:240–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Date K, Kishimoto S, Fujii Y, Togo K, Kakuta Y, Mizuno T, Tsukiya T, Takewa Y, Nishimura T, Ono M, Tatsumi E. Effects of feeding state on anticoagulation in adult goats treated with warfarin. J Artif Organs. 2016;19:301–4.CrossRefPubMedGoogle Scholar
  24. 24.
    Connell JM, Khalapyan T, Al-Mondhiry HA, Wilson RP, Rosenberg G, Weiss WJ. Anticoagulation of juvenile sheep and goat with heparin, warfarin and clopidogrel. ASAIO J. 2007;53:229–37.CrossRefPubMedGoogle Scholar
  25. 25.
    Tsukiya T, Mizuno T, Takewa Y, Tatsumi E, Taenaka Y. Preclinical study of a novel hydrodynamically levitated centrifugal pump for long-term cardiopulmonary support. In vivo performance during percutaneous cardiopulmonary support. J Artif Organs. 2015;18:300–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Cardiovascular system. In: Jones TC, Hunt RD, King NW, editors. Veterinary pathology. 6th ed. New Jersey: Wiley-Blackwell; 1997. pp. 992–5.Google Scholar
  27. 27.
    Miera O, Schmitt KRL, Delmo-Walter E, Ovroutski S, Hetzer R, Berger F. Pump size of Berlin heart EXCOR pediatric device influences clinical outcome in children. J Heat Lung Transplant. 2014;33:817–21.Google Scholar

Copyright information

© The Japanese Society for Artificial Organs 2017

Authors and Affiliations

  • Noritsugu Naito
    • 1
    • 2
  • Yoshiaki Takewa
    • 2
  • Satoru Kishimoto
    • 2
  • Kei Iizuka
    • 2
  • Toshihide Mizuno
    • 2
  • Tomonori Tsukiya
    • 2
  • Minoru Ono
    • 1
  • Eisuke Tatsumi
    • 2
  1. 1.Department of Cardiothoracic Surgery, Graduate School of Medicine University of TokyoTokyoJapan
  2. 2.Department of Artificial OrgansNational Cerebral and Cardiovascular Center, Research InstituteSuitaJapan

Personalised recommendations